Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study | Zendy

Lewis Au | Zendy; Laura Amanda Boos | Zendy; Anthony J. Swerdlow | Zendy; Fiona Byrne | Zendy; Scott T.C. Shepherd | Zendy; Annika Fendler | Zendy; Samra Turajlic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study

Author(s) -

Lewis Au,

Laura Amanda Boos,

Anthony J. Swerdlow,

Fiona Byrne,

Scott T.C. Shepherd,

Annika Fendler,

Samra Turajlic

Publication year - 2020

Publication title -

cell

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 26.304

H-Index - 776

eISSN - 1097-4172

pISSN - 0092-8674

DOI - 10.1016/j.cell.2020.09.005

Subject(s) - biology , covid-19 , immunity , virology , cancer , immunology , immune system , genetics , infectious disease (medical specialty) , disease , medicine , outbreak

The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research